Cargando…
CYTOR drives prostate cancer progression via facilitating AR‐V7 generation and its oncogenic signalling
Autores principales: | Yu, Jianpeng, Shen, Tianyu, Li, Yang, Hao, Tangxi, Yang, Long, Li, Hanlin, Piao, Xuan‐Mei, Zhang, Zheng, Zhu, Shimiao, Quan, Changyi, Kim, Wun‐Jae, Zhao, Yang, Niu, Yuanjie, Shang, Zhiqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154880/ https://www.ncbi.nlm.nih.gov/pubmed/37132132 http://dx.doi.org/10.1002/ctm2.1230 |
Ejemplares similares
-
RETRACTED ARTICLE: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
por: Zhang, Boya, et al.
Publicado: (2021) -
Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
por: Zhang, Boya, et al.
Publicado: (2023) -
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2023) -
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression
por: Shen, Tianyu, et al.
Publicado: (2020) -
High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients
por: Zhang, Zheng, et al.
Publicado: (2018)